about
Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.Efficacy and safety of tenofovir-based rescue therapy for chronic hepatitis B patients with previous nucleo(s/t)ide treatment failure.An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma.Is propofol safe when administered to cirrhotic patients during sedative endoscopy?Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma.Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study.Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea.Current status and strategies for the control of viral hepatitis A in KoreaSevere ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma.Validation of Prognostic Scores to Predict Short-term Mortality in Patients with Acute-on-Chronic Liver Failure.Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors.[A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization].Systemic cytotoxic chemotherapy of patients with advanced hepatocellular carcinoma in the era of sorafenib nonavailability.Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy.Long-term follow-up of chronic hepatitis C patients treated with interferon-alpha: risk of cirrhosis and hepatocellular carcinoma in a single center over 10 yearsClinical Significance of Urinary Neutrophil Gelatinase-associated Lipocalin Levels in Defining the Various Etiologies of Acute Kidney Injury in Liver Cirrhosis Patients[Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients]Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisDifferential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores
P50
Q35898936-63ACDCEC-C7A9-4097-8F23-938E250B1110Q37411328-2D0A29AC-D949-4F39-A94D-9CE87AB241AEQ37564039-6EC2C6F9-2663-4186-B847-BD08A5127CA5Q37570142-906765FB-3B37-4775-B530-54323CDD03AAQ37598823-7554ADA3-2BBE-4D4C-8648-785FC019774FQ37660406-43A48732-0449-4262-97F4-FD08E3D434D4Q40526027-74DEF4E4-9200-4552-BE07-C3AF7BE9DAE3Q41285620-5CDBE0D3-A897-4C0F-9A3C-149E49EA0604Q41811452-8D546B03-29DF-4432-899F-4BA17451E56DQ41842297-5E5B7F06-FD8B-4F29-A2A6-90B3DA8A3652Q42245746-5EA48CBA-CBDC-4E71-A664-624312EA153CQ42433365-19373B9F-FF22-43E3-8FE6-997124267B14Q48332580-DD32B9F8-4EA3-4469-807A-A2B0115E9ECFQ49712719-4BE91DB5-F060-4DAB-A879-B70C2A6B6196Q53332085-DF2316FF-4E51-473D-AAEF-53FC34E2420CQ54408370-4BF3FE90-D24B-4A07-8289-C66E40E33063Q64945139-1A6EBBAF-FCC4-40F3-94DA-65D82A237A1BQ86541979-66588759-4D0E-40C6-A2A5-88A31F966495Q90936650-D25CD51F-241A-4489-B194-9A7606B7D51FQ91440233-BD7BB19C-D4C3-4F7E-85F5-E28B97459F3CQ92056624-DFED9115-B586-41C3-87AB-D2CA1AE814B1Q94958573-4121A42C-5BFF-4571-A927-1FC06C95479B
P50
description
investigador
@es
researcher
@en
name
Eileen L Yoon
@en
type
label
Eileen L Yoon
@en
prefLabel
Eileen L Yoon
@en
P31
P496
0000-0003-0474-048X